Kevin Brennan

6PUBLICATIONS
17CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 18, 2023
Loss of p53-DREAM-mediated repression of cell cycle genes as a driver of lymph node metastasis in head and neck cancer.

Kevin Brennan, Almudena Espín-Pérez, Serena Chang

|Jun 13, 2023
Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma.

Chen Chen, June Ho Shin, Zhuoqing Fang

|Jan 30, 2022
NSD1 mutations deregulate transcription and DNA methylation of bivalent developmental genes in Sotos syndrome.

Kevin Brennan, Hong Zheng, Jill A Fahrner

|Oct 05, 2020
Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma.

Kevin Brennan, Thomas J Metzner, Chia-Sui Kao

|Jul 30, 2019
The impact of DNA methylation on the cancer proteome.

Majed Mohamed Magzoub, Marcos Prunello, Kevin Brennan

|Sep 17, 2016
Development of prognostic signatures for intermediate-risk papillary thyroid cancer.

Kevin Brennan, Christopher Holsinger, Chrysoula Dosiou

Pageof 1